Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
3.515
-0.525 (-13.00%)
Oct 19, 2026, 12:43 PM EDT - Market open
Company Description
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Apimeds Pharmaceuticals US, Inc.
| Country | United States |
| Founded | 2020 |
| IPO Date | May 9, 2025 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Vinod Menon |
Contact Details
Address: 100 Matawan Rd, Suite 325 Matawan, New Jersey 07747 United States | |
| Phone | 848 201 5010 |
| Website | mindwavedao.com |
Stock Details
| Ticker Symbol | APUS |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 1894525 |
| CUSIP Number | 03771D201 |
| ISIN Number | US03771D2018 |
| Employer ID | 85-1099700 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Erik C. Emerson | President |
| Erick J. Frim | Chief Financial Officer |
| Captain Sandeep Singh Yadav | Chief Operating Officer |
| Amardeep Singh | Chief Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 13, 2026 | 8-K | Current Report |
| Oct 1, 2026 | 8-K | Current Report |
| Sep 29, 2026 | 8-K | Current Report |
| Sep 23, 2026 | 8-K | Current Report |
| Sep 11, 2026 | 8-K | Current Report |
| Aug 21, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Aug 6, 2026 | 8-K | Current Report |
| Jul 13, 2026 | 8-K | Current Report |
| May 26, 2026 | 10-Q | Quarterly Report |